Selenium
Active ingredient
Sold as MICRO SE
- Drug class
- -
- Availability
- Over-the-counter
- Routes
- Oral, Intravenous
- Markets covered
- 3
- Products on record
- 5
Overview
Selenium is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 1 | December 5, 2025 |
| US United States | FDA | 2 | October 6, 2023 |
| CA Canada | Health Canada | 2 | December 19, 2025 |
GBUnited Kingdom· MHRA
1 product
Uses
Prevention of selenium deficiency in patients receiving parenteral nutrition. Treatment of proven selenium deficiency that cannot be compensated by nutrition alone.
How to take
USUnited States· FDA
2 products
2 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [2].
CACanada· Health Canada
2 products
2 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [3].
Brands in Canada (1)
Drug interactions
Known interactions involving Selenium. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL144340030 · revised December 5, 2025
- [2]FDA DailyMed · 0672ea34-e65e-10… · revised September 28, 2023 [PDF]
- [3]Health Canada (DPD) · 01986007 · revised December 19, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.